CORDIS
EU research results

CORDIS

English EN

Exploring Functional and Developmental Osteoclast Heterogeneity in Health and Disease

Project information

Grant agreement ID: 607446

Status

Closed project

  • Start date

    1 September 2013

  • End date

    31 May 2018

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 3 135 351,34

  • EU contribution

    € 3 135 351,34

Coordinated by:

STICHTING VU

Netherlands

Objective

Euroclast proposes a research training program on osteoclast biology in the context of osteoclast-driven diseases. Osteoclasts are the complex, multinuclear cells responsible for bone breakdown. Many diseases of osteoclast malfunctioning manifest in bone loss, for example, osteoporosis, cancer-induced bone disease, periodontitis, or rheumatoid arthritis, all conditions set to increase in an ageing EU population. The Euroclast consortium (7 academic, 2 private and 1 ass. partner) focuses on osteoclast heterogeneity, a recent insight that poses new fundamental questions best tackled by a multi-partner consortium capable of assembling the sophisticated molecular, genetic and imaging tools required. We will analyze changes in gene and protein expression during osteoclast (trans)differentiation from different precursor cell pools and in various bone sites and relate this to osteoclast activity and sensitivity to therapeutics. The osteoclast resorptive
apparatus will be studied using in depth and will define the key enzymatic and molecular machinery to be translated into novel site-specific drug targets or biomarkers. High throughput screening assays for therapeutics and ELISAs for biomarkers will be developed with our private partners. Our multidisciplinary and cross-sectorial approach will improve understanding and treatment of common disorders associated with osteoclast malfunction and train 11 early stage researchers (ESRs) in modern cell and bone biology. We will provide extensive training in generic skills and all ESRs will spend time with our private partners and be seconded to other academic partners to ensure they are well equipped for employment in research and industrial settings. Euroclast will produce an on-line repository for osteoclast protocols, make methodological and scientific advances in osteoclast and bone biology and create a sustainable network of ESRs and senior academics to tackle diseases of bone loss into the future.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

STICHTING VU

Address

De Boelelaan 1105
1081 Hv Amsterdam

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 746 011,42

Participants (9)

THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN

United Kingdom

EU Contribution

€ 604 213,28

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

Germany

EU Contribution

€ 227 568,88

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 265 425,16

GOETEBORGS UNIVERSITET

Sweden

EU Contribution

€ 265 425,16

TECHNISCHE UNIVERSITAET DRESDEN

Germany

EU Contribution

€ 227 568,88

TURUN YLIOPISTO

Finland

EU Contribution

€ 266 697,64

NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S

Denmark

EU Contribution

€ 290 079,46

FUTURE DIAGNOSTICS BV

Netherlands

FUTURE DIAGNOSTICS SOLUTIONS BV

Netherlands

EU Contribution

€ 242 361,46

Project information

Grant agreement ID: 607446

Status

Closed project

  • Start date

    1 September 2013

  • End date

    31 May 2018

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 3 135 351,34

  • EU contribution

    € 3 135 351,34

Coordinated by:

STICHTING VU

Netherlands

This project is featured in...